Loading...

NEXTGEN GENECORE PARADIGM EXTENDED 1000 GENE PANEL

image not found

NABL Cap Accredited 
The NextGen GeneCore Paradigm Extended 1000 Gene Panel at Metropolis Healthcare is an ultra–comprehensive genomic profiling test designed to analyze over 1000 cancer-associated genes. This advanced panel detects mutations, fusions, copy number variations, and complex genomic signatures to support precision oncology. Metropolis Healthcare uses high-depth Next-Generation Sequencing and robust bioinformatics to deliver accurate, clinically actionable insights. It is ideal for patients requiring extensive molecular characterization for targeted therapy, immunotherapy guidance, and long-term treatment planning.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 160,000.00

Sample Type: Tissue

Fasting Not Required


Notes:N8219

Frequently Asked Questions (FAQ's):

What does the GeneCore Paradigm Extended 1000 Gene Panel at Metropolis Healthcare include?
It analyzes 1000+ cancer-related genes to detect mutations, fusions, CNVs, and other clinically relevant genomic alterations.

How does Metropolis Healthcare perform this extensive genomic panel?
Metropolis Healthcare uses high-coverage NGS with advanced bioinformatics pipelines to ensure precise and reliable tumor profiling.

Who should consider taking this test at Metropolis Healthcare?
Patients with solid tumors who need broad molecular insights for targeted therapy or immunotherapy planning should opt for this panel.

Is fasting required for this test at Metropolis Healthcare?
No fasting is required; the test is performed on tumor tissue and/or blood samples based on clinical recommendations.

How long do results take at Metropolis Healthcare?
Results typically take 2–3 weeks due to the detailed sequencing and interpretation of 1000+ genes.

Can this test at Metropolis Healthcare help identify targeted therapies?
Yes, the panel highlights actionable mutations linked to multiple approved and emerging targeted treatments.

How accurate is the 1000-gene sequencing performed by Metropolis Healthcare?
Metropolis Healthcare ensures high analytical accuracy through deep sequencing coverage and stringent quality controls.

Does this panel support long-term cancer management at Metropolis Healthcare?
Yes, the comprehensive genomic data helps clinicians plan personalized treatment strategies and monitor disease progression effectively.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab